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Introduction
Melatonin is a relevant hormone controlling various physiological actions, many of which are related to the photoperiod (Pandi-Perumal et al., 2006) . It is generally accepted that blood melatonin levels increase overnight as a consequence of its production and release from the pineal gland (Caprioli and Sears, 1984; Alarma-Estrany and Pintor, 2007; Stehle et al., 2011 ).
This gland is not exclusively responsible for melatonin production. In the orbital cavity and in the eye, for instance, some areas such as the retina (Cardinali and Rosner, 1971a; Cardinali and Rosner, 1971b; Alarma-Estrany and Pintor, 2007) , ciliary body (Martin et al., 1992; AlarmaEstrany and Pintor, 2007) and harderian glands (Djeridane et al., 1998; Alarma-Estrany and Pintor, 2007) , have the ability to synthesise and release melatonin. As occurs in other tissues, the eye melatonin exerts many of its actions by means of membrane receptors termed melatonin receptors, divided into MT 1 , MT 2 and the putative MT 3 melatonin receptors (AlarmaEstrany and Pintor, 2007; Dubocovich et al., 2010) .
One significant physiological process in the eye undergoing circadian control is the regulation of the intraocular pressure (IOP). IOP is the result of the balance between the production of the aqueous humour by the ciliary body (Civan and Macknight, 2004; Do and Civan, 2004) and its drainage by the trabecular meshwork and uvesoscleral pathway (An and Ji, 2011; Pattabiraman et al., 2012) . In this sense, the circadian fluctuation of IOP has been widely studied (Rowland et al., 1981; Liu et al., 2011) , as well as its melatonin levels relationship (Samples et al., 1988) . Interestingly, this circadian pattern can be modified by applying exogenously melatonin or any of its analogues (Pintor et al., 2001; Serle et al., 2004) . In this sense, the topical application of melatonin on the ocular surface produces a transient reduction in IOP which is enhanced by melatonin analogues such as 5 methylcarboxyamino N-acetyl tryptamine (5-MCA-NAT) or N-Butanoyl 2-(9-methoxy-6H-iso-indolo[2,1-a]indol-11-yl)-ethan-amine (IIK7) . Melatonin and these two analogues acting through MT 3 and MT 2
From a therapeutic point of view, the implications of melatonin and analogues on IOP control are relevant. IOP is elevated in primary open angle glaucoma, affecting more than 65 million patients all over the world (Quigley and Broman, 2006) . In most of the cases, the treatment for the reduction of the abnormally elevated IOP is by means of adrenergic compounds, carbonic anhydrase inhibitors, prostaglandins or parasympathomimetics (Webers et al., 2008; Lee and Goldberg, 2011; Carta et al., 2012) . Since melatonin reduces IOP in experimental models it would be of interest to see whether this effect is also feasible in humans.
In this sense, some ophthalmologists have started to use melatonin to reduce IOP in patients undergoing cataract surgery, indicating the relevance of this molecule as regulator of IOP (Ismail and Mowafi, 2009) , suggesting its possible use as a treatment of ocular hypertension.
The actions of melatonin in the reduction of IOP are taking place mainly on the ciliary body as commented above. Interestingly, the actions melatonin and analogues can exert on this part of the eye, are not only the short-term IOP reduction (Pintor et al., 2001; Pintor et al., 2003) but they also produce a long-term effect. This second aspect of melatonin action is due to the modification in the expression of key genes encoding for proteins relevant in the control of aqueous humour production such as adrenergic receptors (Crooke et al., 2011) and carbonic anhydrases (Crooke et al., 2012) . These proteins indirectly regulate water efflux, therefore controlling aqueous humour production and subsequently IOP.
On the contrary, little is known about the mechanisms of IOP rapid reduction by melatonin or 5-MCA-NAT. It is supposed that melatonin and analogues may also modify the aqueous humour water production, but to date there is no evidence of the possible mechanism involved.
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To equilibrate intracellular and extracellular buffer chloride concentration, 10μM tributyltin (Sigma) and 5μM nigericin (Sigma) were added to the buffer. Applying changes in fluorescence in cells under these different chloride buffers, a Stern-Volmer plot was obtained, responding to the equation:
Where F 0 are the MQAE fluorescence in absence, F in presence of chloride and K sv (SternVolmer constant) is the slope of linear plot representing the efficiency of collisional quenching.
Concentration-response curves
To determine concentration-response curves, different concentrations of melatonin (Sigma) and 5-MCA-NAT (Tocris) were tested according to the previous methodology. Concentrations tested varied in ranges from 1 nM to 150μM. The Fmax and the slope of the straight segment of each dose curve were converted into % of fluorescence (F t -F 0 ) versus control (taken as 100%) and plotted. Data are plotted as % of mean fluorescence (vs. control) in RFU ± s.e.m., versus logarithm of agonist concentration.
Cyclic AMP Studies
Cyclic AMP accumulation was measured using cAMP Enzyme Inmune Assay EIA KIT (Cayman Chemical Company, Ann Harbor, USA). Cells were grown to confluence in 6-wells plates (Iwaki). Then, medium was replaced with fresh medium containing different concentration of agents. Antagonist were pre-incubated during 15 minutes and after 10 minutes of incubation with agonists, the medium was removed and immediately each well was incubated for 20 minutes containing 275 μ l HCl 0.1M. The cells were then scraped and centrifuged at 1000xg during 10 minutes, and the supernatant was assayed as indicated in the protocol of cAMP Cayman EIA Kit. The results were expressed as pmol/ml to avoid errors due to the resuspension and protein quantification in small volumes.
A ll wells were examined before the assay and cells were counted, to ensure homogeneity of the study. Results were shown as a mean ± s.e.m.
Statistical analysis
GraphPad Prism (GraphPad software Inc. San Diego, USA) was used to obtain the linear 
RESULTS

Effect of melatonin and 5-MCA-NAT on ciliary body epithelial cells
MQAE is a high sensitive chloride fluorescence probe. This fluorescence is quenched in presence of chloride, so that changes in fluorescence are inversely proportional to changes in chloride concentration. Using protocol specified in methods, it was possible to verify the linear relationship between dye fluorescence and intracellular chloride concentrations in this cell type ( Figure 1A ). Using this data it was also possible to calculate the Stern-Volmer constant (K sv ), whose value was 12.18 ± 0.89 M -1 (n=6), in rabbit NPE cells. This constant permits us to calculate the intracellular Cl -concentration which was 74.37±3.8 mM (n=6) in rabbit nonpigmented ciliary epithelial cells when external Cl -concentration was 130 mM.
Using this fluorescence probe, we were able to measure changes in the intracellular chloride concentrations after challenging the cells with melatonin and analogues. In particular, melatonin and 5-MCA-NAT were able to modify intracellular chloride. Normalized plots of fluorescence vs.
time always presented sigmoid patterns. From these plots, three different parameters were calculated: On the one hand, the maximal fluorescent signal, Fmax, which corresponded to the minimal intracellular chloride concentration ([Cl -] i ). On the other hand t 50 , which corresponded to the time necessary to produce 50% of Fmax that is an indication of how fast the release of chloride was. Finally, the slope of the curve straight segment representing the velocity (V) of the chloride efflux. We have used these parameters to evaluate the treatments versus the untreated cells which were taken as controls. These control cells showed the normal release of chloride of this cell type in chloride-free buffer. As previously indicated, non-treated cells depicted a sigmoid behaviour that was consistent to a chloride efflux from inside the cells to the extracellular milieu ( Figure 1B ). From this curve it was possible to calculate Fmax, t 50 and V values presented in table 1.
Melatonin and 5-MCA-NAT (100 μM), clearly and significantly changed the Cl -efflux as can be seen in Figure 1B . There were differences in the Fmax, t 0.5 and V, when comparing melatonin and 5-MCA-NAT with control ( Figure 2 , table 1). Interestingly, both melatonin and 5-MCA-NAT showed a strong inhibition when compared to control. Indeed, melatonin completely inhibited chloride release for about 602 s (10.0 min) and 5-MCA-NAT for roughly 860 s (14.3 min). After that, and in the presence of these two compounds, the slope of their respective curves was not as steep as the control and moreover, they did not reach the Fmax the control did ( Figure 1B ).
1
Concentration-response curves for melatonin and 5-MCA-NAT
In order to fully study the effect of melatonin and 5-MCA-NAT on chloride fluxes, cells were challenged with graded concentrations of both compounds following the protocol described in methods. We focused on how these two compounds were able to diminish cell fluorescence (Fmax) and its concentration dependency. In this sense, and as can be seen in Figure 2A , both compounds depicted concentration-response curves which were almost identical. From both curves it was possible to obtain pD 2 value of 4.5 ± 1.2 for melatonin and 4.4 ± 1.0 for 5-MCA-NAT (n=5). These values corresponded to EC 50 values of 31.6 μM and 39.8 μM for melatonin and 5-MCA-NAT respectively.
When, instead of studying the relationship between concentration and cell fluorescence, we analysed concentration vs. changes in the slope (velocity) for melatonin, 5-MCA-NAT, sigmoidal curves were obtained, providing interesting data. As observed in Figure 2A , melatonin presented a pD 2 value of 4.7 ± 0.2, while 5-MCA-NAT provided a pD 2 value of 5.0 ± 0.1, corresponding to EC 50 values of 19.9 μM and 10 μM for melatonin and 5-MCA-NAT respectively (n=5). Interestingly, the Hill slopes for both compounds were different, their values being 0.6 ± 0.3 for melatonin and 1.8 ± 0.2 for 5-MCA-NAT ( Figure 2B ) (n=5).
Studies with antagonists
Although the presence of melatonin receptors, mainly MT 2 and MT 3 have already been described in the ciliary body non-pigmented epithelial cells, we have tried to investigate which receptor is involved in the changes in the intracellular chloride concentrations. In this sense, the MT 2 antagonist 4-P-P-DOT was unable to modify the effect of melatonin. (Figure 3 ). In the same sense, prazosin (MT 3 antagonist receptor) 15nM, surprisingly enhanced the effect of 5-MCA-NAT to 29.5±4.3 %. Nevertheless, the values were very close to those of 5-MCA-NAT alone (44.8±3.5 %) when we used prazosin 150nM, and partially reverted 5-MCA-NAT effect (78.3±16.5 %) when it was used at 1.5µM concentration (n=6) ( Figure 4A ).
Similar results were obtained using melatonin (n=6) ( Figure 4B ), however no statistical significance differences were reached between melatonin and melatonin + prazosin 15 nM. This lack of statistical significance difference is probably due to a relatively high S.E.M regarding "n" used, and not to a difference in the behavior of both substances.
Adrenoreceptors Alpha 1 implications in chloride regulation
The results obtained with prazosin at a low concentration, produced an enhancement of 5-MCA-NAT hypotensive effect while at high concentration it produced the partial inhibition of 5-MCA-NAT effect suggesting the involvement of an adrenoreceptor alpha-1 in the regulation of chloride secretion.
As is shown in Figure 5A and 5B (n=6), corynanthine (alpha-1 antagonist) was able to enhance the effect of 5-MCA-NAT on chloride efflux from 43.36±5.53% to 28.18±3.46%, confirming the role of alpha-1 receptors in the regulation of chloride flux. Corynanthine alone has no effect on the chloride secretion (data not shown).
Second messengers triggered by melatonin and 5-MCA-NAT
It has been claimed that MT 3 melatonin receptors are coupled to phospholipase C/protein kinase C (PLC/PKC) pathway (Huang et al., 2001) . In order to see whether the effect of melatonin and 5-MCA-NAT was triggering the mentioned intracellular pathway, different
blocking agents of this route were tested in their ability to modify the Cl -effluxes triggered by melatonin and 5-MCA-NAT.
As is shown in Figure 6 , none of the compounds tested to inhibit the PLC-PKC pathway was able to produce a change in the fluorescence signal either alone or in the presence of melatonin or 5-MCA-NAT.
Involvement of cAMP pathway
We decided to investigate the canonical cAMP pathway which has been described to be negatively coupled to both MT 1 and MT 2 receptors. When adenylate cyclase activity was increased by means of a forskolin and IBMX mixture (see methods), we could notice a reduction in Cl -efflux as observed in Figure 7A . Since the chloride efflux triggered by adenylate cyclase activation resembled the behaviour of melatonin and 5-MCA-NAT, we studied the ability of these two substances to increase cAMP concentrations. The results showed that melatonin 100μM was able to increase intracellular cAMP levels of 58.05 ± 4.22 to 84.59 ± 6.78 pmol/ml (n=6). In the case of 5-MCA-NAT, 100μM results were similar, obtaining an intracellular cAMP concentration of 90.55 ± 5.53 pmol/ml (n=6) in the presence of the melatonin analogue.
Different concentrations of melatonin and 5-MCA-NAT were tested to characterize the dose-dependent behaviour of these substances. As shown in Figure 7B , graded concentrations of melatonin and 5-MCA-NAT evoked the accumulation of concomitant amounts of cAMP in rabbit NPE cells. The concentration-response curve provided a pD 2 value of 4.6 ± 0.2 for melatonin and 4.9 ± 0.7 for 5-MCA-NAT, which were equivalent to EC 50 values of 22.0 μM and 19.4 μM (n=6) for melatonin and 5-MCA-NAT respectively.
To investigate the involvement of the MT 3 receptor in this signalling pathway we blocked this receptor using prazosin 1.5 µM (n=6), measuring the accumulation of intracellular cAMP.
The results were presented in Figure 8 . Data showed a partial and significant reversion of respectively. After this interval of inhibition the rate of efflux increases, even though slope and Fmax, were always below the control values. This fact indicates that the inhibitory effect does
not only affect initial chloride efflux but inhibition was also present when the equilibrium was reached (see Figure 1 ). The substantial inhibition of the chloride release and the presumable inhibition of the aqueous humour formation seem to be higher than the IOP reduction observed "in vivo" (Pintor et al., 2003) . In this sense, it is important to notice that the "in vitro" model we are using, although mimicking the conditions present in the ciliary body, has certain limitations.
One of the main "in vitro" restrictions is that we are measuring the secretory layer NPE cells, producers of the aqueous humour, and not the drainage system, possibly the reason for such differences. Another limitation to take into consideration is that the measurements we have performed involve only Cl -efflux processes. This implies that there is a Cl -efflux following a concentration gradient (as occurs in the "in vivo" model) and, due to the lack of this ion in the extracellular buffer, mechanisms transporting this ion from the extracellular space to NPE cells cytoplasm are not fully activated. Consequently, the data obtained are dependent solely on the state of chloride channels and transporters. Also, we should emphasize the absence of the pigment epithelium (PE), which takes chloride from stromal and transfers it to NPE layer cells.
The importance of PE and its function has been extensively described in the literature (McLaughlin et al., 1998; Do and To, 2000; Do et al., 2004a; Ni et al., 2006) . However, the simultaneous study of both layers complicates precise conclusions concerning the contribution of each structure involved.
Although there are some limitations in the model we are using, it is important to emphasize that an analysis of the concentration-curves demonstrates that the effects depicted by melatonin and 5-MCA-NAT were highly similar but not identical (especially in Fmax), as we can see in Figure 1 . This matches the results obtained for both substances on IOP in New Zealand white rabbits, where the effect of melatonin as an hypotensive agent is less robust than that of 5-MCA-NAT (Pintor et al., 2003) . in the cytosolic concentration of cAMP, since, as already mentioned above, MT 1 or MT 2 melatonin receptors are negatively coupled to adenylate cyclase (Vanecek, 1998) . The study on the ability of melatonin and 5-MCA-NAT to inhibit cAMP formation pointed in the opposite direction as it was impossible to see a reduction in cAMP production. On the contrary, we could observe that melatonin and its analogue increased cAMP concentrations in a concentrationdependent manner. This is not a common mechanism of signal amplification but it has been described in some models (Raviola, 1974; Beraldo and Garcia, 2005; Schuster et al., 2005) .
Indeed it modified chloride efflux, and this effect was mimicked when we applied forskolin and IBMX. The relationship between the increase of cAMP and the decrease of IOP is widely studied in the eye. In rabbits and monkeys, it is known that this decrease in IOP is associated to a significant decrease in AH secretion. Interestingly, it has been reported that 5-MCA-NAT is able to produce important increases in cAMP in chick retinas by a mechanism that may involve an MT 3 (Mel1c) binding site (Sampaio Lde, 2009 ).
When the involvement of the putative MT 3 melatonin receptor was studied, the use of the only available antagonist prazosin was tested. Low concentrations of this antagonist produced an unexpected potentiation of the action triggered by 5-MCA-NAT. Nevertheless, at higher concentrations (1.5 μM), prazosin did its antagonistic effect blocking melatonin and 5-MCA-NAT actions, indicating that at low micromolar concentrations it acts as a MT 3 receptor antagonist as previously described elsewhere (Dubocovich et al., 2003; Pintor et al., 2003; Alarma-Estrany et al., 2011) .
Concerning the results obtained with prazosin at nanomolar concentrations, the observed contradictory effect potentiating 5-MCA-NAT action can be explained as an effect performed on alpha-1 adrenoceptors. This point was confirmed when the same effect was obtained with the selective alpha-1 adrenoceptor antagonist corynanthine, as was also described regarding the modulation of IOP in rabbits by other authors (Chidlow et al., 2001 ).
This article has not been copyedited and formatted. The final version may differ from this version. In the same way, we tested the action of prazosin, in micromolar range, on the cAMP accumulation induced by 5-MCA-NAT. Prazosin was able to partially revert the increased intracellular cAMP. This fact relates the cAMP increase with the MT 3 melatonin receptor.
It has been demonstrated that the chloride efflux from NPE cells is one of the most, if not the most important, ion controlling aqueous humour secretion as previously commented (Jacob and Civan, 1996; Forrester, 2002) . However, the nature of the proteins ruling the movement of Cl - (JC, 1989; Paulmichl et al., 1992; Chen et al., 1999; Do et al., 2006) The results obtained in this study, suggest that a prazosin sensitive melatonin receptor, different from the MT 1 or MT 2 , is responsible for the decrease in Cl -outflow. Both melatonin and 5-MCA-NAT would bind to the three melatonin receptor subtypes, probably with different affinity.
MT 1 /MT 2 receptors produce an opposite effect on intracellular cAMP levels, but not so intense as the non-cloned melatonin receptor (putative MT 3 receptor) would do. This could explain the observed effect when the inhibition of MT 1 and MT 2 melatonin receptors is performed.
Differences in the affinity of the agonists for each receptor subtype, may explain the observed changes in cAMP at non-saturating concentrations of these two agonists. When melatonin acts, it does so mainly through MT 1 /MT 2 receptors while 5-MCA-NAT by MT 2 and preferentially by MT 3 . Also, there is more and more evidence pointing to melatonin receptor heterodimerization to explain these differences. In this sense, Ayub and co-workers have described that MT 2 melatonin receptors can form heterodimers with MT 1 receptors, and that the formation of these heterodimers modifies the affinity for the agonists and antagonists (Ayoub et al., 2004) . that involves cAMP increase. This might be the potential mechanism to reduce and modulate net aqueous humour secretion explaining why melatonin and some of its analogues can reduce IOP in experimental animals (Pintor et al., 2001; Pintor et al., 2003) .
This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version.
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: : 1 6 3 1 -1 6 4 1 . : C 9 7 9 -9 9 1 . Antagonists for melatonin receptors at the concentrations described in our methods, were tested in their ability to block melatonin and 5-MCA-Nat effects. All data are expressed as % of the normal (control) chloride intracellular concentration at Fmax. Antagonists did not reverse melatonin and 5-MCA-NAT effect, and on the contrary, they were able to increase melatonin and 5-MCA-NAT effect (***p<0.001; n=6). Values are the mean ± s.e.m. Addition of prazosin 1.5 µM with 5-MCA-NAT 100 µM as described in methods. Prazosin was able to partially revert the cAMP accumulation produced by 5-MCA-NAT (p<0.05, n=6). Data of F max , T 50 and slope are expressed as mean ± s.e.m. 
